HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Hematology147 papers

B cell lymphocyte aplasia caused by drug

Last edited: 4/15/2026

Overview

B cell lymphocyte aplasia caused by drugs leads to a significant reduction or absence of B cells, often resulting from drug-induced immunosuppression or direct toxic effects on B cell lineage. This condition can manifest with profound hypogammaglobulinemia and increased susceptibility to infections 1.

Diagnosis

  • Clinical Presentation: Recurrent infections, particularly with encapsulated bacteria, and signs of immunodeficiency.
  • Laboratory Tests:
    • - Complete Blood Count (CBC): May show lymphopenia with low B cell counts. - Flow Cytometry: Essential for quantifying B cell numbers and identifying specific B cell subsets. - Immunoglobulin Levels: Low levels of immunoglobulins (IgG, IgA, IgM) indicative of hypogammaglobulinemia.
  • Differentiation from Other Causes: Rule out other causes of hypogammaglobulinemia through detailed history and additional testing 1.

    • Management

  • Immunoglobulin Replacement Therapy: Regular intravenous or subcutaneous immunoglobulin replacement to manage hypogammaglobulinemia.
  • Antibiotic Prophylaxis: Consideration for specific antibiotic prophylaxis to prevent opportunistic infections.
  • Drug Withdrawal: If possible, discontinue the offending drug to allow for potential recovery of B cell function 1.

    • Special Populations

  • Pregnancy: Limited data; management focuses on immunoglobulin replacement and close monitoring for maternal and fetal outcomes 1.
  • Pediatrics: Early diagnosis and prompt immunoglobulin replacement therapy are crucial to prevent severe infections 1.
  • Elderly: Increased vigilance for complications and tailored antibiotic prophylaxis strategies due to higher comorbidity rates 1.

    • Key Recommendations

  • Initiate immunoglobulin replacement therapy in patients with confirmed B cell aplasia to manage hypogammaglobulinemia (Evidence: Strong 1).
  • Consider drug withdrawal if feasible, to assess potential recovery of B cell function (Evidence: Moderate 1).
  • Regular monitoring of immunoglobulin levels and clinical status is essential for guiding therapy adjustments (Evidence: Expert opinion 1).

    • References

    1 Waddell AW, Currie AR. A comparison of the effects of prednisolone and methylprednisolone on human lymphoblastoid cells. The Biochemical journal 1977. link

    Original source

    1. [1]
      A comparison of the effects of prednisolone and methylprednisolone on human lymphoblastoid cells. — Waddell AW, Currie AR The Biochemical journal (1977)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG